Tranexamic Acid Tablet
Product Images NDC 72603-818

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tranexamic Acid (NDC 72603-818). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Tranexamic Fig1)

A line graph depicting mean menstrual blood loss (mL) over multiple treatment cycles, comparing Tranexamic Acid 3900 mg/day with placebo in both 3-cycle and 6-cycle studies. The x-axis shows treatment periods from baseline through sixth cycle, and the y-axis shows mean blood loss ranging from 80 to 200 mL. Multiple lines represent different study groups showing trends across cycles.*

FDA Label Image

Package Label-principal Display Panel (650 mg (30 Tablets Bottle))

Packaging label for Tranexamic Acid Tablets USP, 650 mg strength, presented in a bottle of 30 tablets. The label shows the NDC number 72603-818-01 and indicates the product is manufactured for NorthStar Rx LLC. Usage and storage instructions are included, along with manufacturing details from Aurobindo Pharma Limited, India.*

FDA Label Image

Chemical Structure (Tranexamic Str)

Chemical structure of tranexamic acid showing the spatial arrangement of its cyclohexane ring with attached amino and carboxylic acid groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.